Roche launches US$5.75bn bond to back InterMune deal -lead
September 22, 2014 at 13:38 PM EDT
NEW YORK, Sept 22 (IFR) - Swiss drugmaker Roche has launched a six-part US$5.75bn bond which will back its acquisition of InterMune, according to sources close to the deal.
